CF PHARMTECH (02652) spent 264,400 Hong Kong dollars to repurchase 14,500 shares on June 10th.
Changfeng Pharmaceuticals (02652) announced that on June 10, 2026, they bought back 14,500 shares at a cost of 264,400 Hong Kong dollars.
CF PHARMTECH (02652) announced that it will spend 264,400 Hong Kong dollars to repurchase 14,500 shares on June 10, 2026.
Related Articles
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
RECOMMEND
